Generic name: nitrofurantoin and macrocrystalline
Used for: Urinary tract infections
Lowest to pick up today
$17.36 for 30 capsules
Generic nitrofurantoin and macrocrystalline 100 mg with the free Team Cuban Card, at pharmacies that take it
By mail, if you can wait a few days $14.39 for 30 capsules delivered ($9.14 plus $5.25 shipping) from Cost Plus Drugs. Make a free account, then have your prescription sent there.
Open Cost Plus DrugsA regular generic has the same active ingredient as Macrobid, and the FDA requires it to work the same way.
Details for each option
We didn’t find a savings card or cash price from Macrobid’s maker. Ask the pharmacy for Macrobid’s cash price. With insurance, ask what your plan charges.
The same medicine as Macrobid, without the brand name. Give the pharmacy its NDC to get it.
nitrofurantoin and macrocrystalline
Source: FDA, updated October 30, 2026
“Before you fill my Macrobid, can you tell me what I’d pay for the brand, for the authorized generic from Alvogen (NDC 47781-303-01), and for a regular generic?”
Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.
Official labels and ingredient lists from DailyMed (U.S. National Library of Medicine).
Same active and inactive ingredients as Macrobid.
Active: nitrofurantoin 25 mg · nitrofurantoin monohydrate 75 mg
Inactive, on both labels:
Pharmacies’ own cash prices for generic nitrofurantoin and macrocrystalline, lowest first.
Pick up in storeDelivered
From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
7 companies sell a generic of Macrobid that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40
100 mg Opaque Black and Opaque Yellow, capsule, 21 mm, marked “Z / 66”
| Package | NDC |
|---|---|
| Bottle of 100 | 65862-929-01 |
Inactive ingredients: carbomer homopolymer type a (allyl pentaerythritol crosslinked), carbomer homopolymer type b (allyl pentaerythritol crosslinked), sucrose, starch, corn, lactose monohydrate, magnesium stearate, povidone k90, povidone k30, talc, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, gelatin, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40 · Made by Mankind Pharma
100 mg Opaque cap and opaque body, capsule, 19 mm, marked “Lifestar / 404”
| Package | NDC |
|---|---|
| Bottle of 100 | 68001-606-00 |
Inactive ingredients: carbomer homopolymer type b (allyl pentaerythritol crosslinked), starch, corn, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, FD&C Red No. 3, gelatin, lactose monohydrate, magnesium stearate, potassium hydroxide, povidone k30, povidone k90, shellac, sucrose, talc, titanium dioxide
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40 · Made by Inventia Healthcare
100 mg Cap-Black and Body-Yellow, capsule, 20 mm, marked “100 / 102”
| Package | NDC |
|---|---|
| Bottle of 100 | 59746-762-01 |
| Bottle of 1000 | 59746-762-36 |
100 mg Cap-Black and Body-Yellow, capsule, 20 mm, marked “100 / 102”
| Package | NDC |
|---|---|
| Bottle of 100 | 59746-762-06 |
| Bottle of 1000 | 59746-762-15 |
Inactive ingredients: starch, corn, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, gelatin, isopropyl alcohol, lactose monohydrate, magnesium stearate, mannitol, povidone k30, povidone k90, sodium lauryl sulfate, talc, titanium dioxide, carbomer homopolymer type b (allyl pentaerythritol crosslinked)
Has lactose
100 mg Black and yellow, capsule, 19 mm, marked “MICRO / 100”
| Package | NDC |
|---|---|
| Bottle of 90 | 42571-393-90 |
| Bottle of 100 | 42571-393-01 |
| Bottle of 500 | 42571-393-05 |
Inactive ingredients: gelatin, lactose monohydrate, magnesium stearate, povidone, talc, titanium dioxide, carbomer homopolymer type b (allyl pentaerythritol crosslinked), sucrose, ferrosoferric oxide, hypromelloses, ferric oxide yellow, starch, corn, shellac, potassium hydroxide
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40 · Made by Mankind Pharma
100 mg Opaque cap and opaque body, capsule, 19 mm, marked “lifestar / 404”
| Package | NDC |
|---|---|
| Bottle of 100 | 72603-196-01 |
Inactive ingredients: carbomer homopolymer type b (allyl pentaerythritol crosslinked), starch, corn, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, FD&C Red No. 3, gelatin, lactose monohydrate, magnesium stearate, potassium hydroxide, povidone k30, povidone k90, shellac, sucrose, talc, titanium dioxide
Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40
100 mg Black and ivory, capsule, 21 mm, marked “E122”
| Package | NDC |
|---|---|
| Bottle of 100 | 0185-0122-01 |
| Bottle of 1000 | 0185-0122-10 |
Inactive ingredients: carbomer homopolymer type b (allyl sucrose crosslinked), D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, gelatin, lactose monohydrate, magnesium stearate, povidone, silicon dioxide, starch, corn, talc, titanium dioxide, sucrose
Made by Sunny Pharmtech
100 mg Opaque yellowish brown and pale yellow, capsule, 22 mm, marked “101”
| Package | NDC |
|---|---|
| Bottle of 100 | 13811-719-10 |
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Macrobid is indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus.
Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Macrobid and other antibacterial drugs, Macrobid should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with Macrobid are predisposed to persistence or reappearance of bacteriuria. (See CLINICAL STUDIES.) Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with Macrobid, other therapeutic agents with broader tissue distribution should be selected. In considering the use of Macrobid, lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.
Source: the FDA label for Macrobid (Almatica Pharma LLC), October 14, 2025. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/macrobid/